Reductive amination process for preparation of dronedarone using amine intermediary compound
A technology of compounds and reducing agents, applied in the fields of organic chemistry, drug combination, cardiovascular system diseases, etc., can solve the problem that the steps cannot be purified.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0168] N-[2-Butyl-3-{4-[(3-dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl]methanesulfonamide (I)
[0169] Dissolve 1 g of N-[2-butyl-3-{4-[(3-amino)propoxy]benzoyl}-1-benzofuran-5-yl]-methanesulfonamide in 30 ml of dichloromethane middle. 0.5 g of butyraldehyde and 1.8 g of triacetoxyborohydride were added, and the reaction mixture was stirred at 20° C. for 12 hours. The reaction mixture was evaporated and the residue was dissolved in isopropyl acetate. Dilute the solution with 20ml water, 10ml5%NaHCO 3 solution and washed with 10ml of water. The solvent was evaporated.
[0170] Yield: 1.21g (94.5%).
[0171] The product was purified by forming its oxalate salt as follows: 6 ml methyl ethyl ketone was added to the residue and the mixture was heated to 70°C. To this solution was added 0.26 g of oxalic acid dissolved in 2.5 ml of methyl ethyl ketone at 70°C. Cool to 20°C over 6 hours, then stir the mixture at 10°C for 1 hour and filter. To the resulting oxalate was adde...
Embodiment 2
[0176] N-[2-Butyl-3-{4-[(3-dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl]methanesulfonamide (I)
[0177] 1 g of N-[2-butyl-3-{4-[(3-amino)propoxy]benzoyl}-1-benzofuran-5-yl]methanesulfonamide was dissolved in 12 ml of butyric acid. 0.2 g of butyraldehyde and 0.26 g of sodium borohydride were added. The mixture was stirred at 55°C for 8 hours. Cool to 0°C and add 20ml of water. The mixture was made strongly basic with solid potassium hydroxide and extracted with 2x20ml dichloromethane. Dilute the solution with 25ml of water, 15ml of 5%NaHCO 3 Washed with 10ml of water and evaporated.
[0178] Yield: 1.10g (85.9%)
[0179] The product was purified according to Example 1 by its oxalate salt (87%).
[0180] Product purity: 99.6% (HPLC). The product was identical to the compound prepared in Example 1.
Embodiment 3
[0182] N-[2-Butyl-3-{4-[(3-dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl]methanesulfonamide (I)
[0183] 1 g of N-[2-butyl-3-{4-[(3-amino)propoxy]benzoyl}-1-benzofuran-5-yl]methanesulfonamide was dissolved in 12 ml of butyric acid and 0.39 g sodium borohydride was added. The mixture was stirred at 55°C for 8 hours. Cool to 0°C and add 20ml of water. The mixture was made strongly basic with solid potassium hydroxide and extracted with 2x20ml dichloromethane. Dilute the solution with 25ml of water, 15ml of 5%NaHCO 3 Washed with 10ml of water and evaporated.
[0184] Yield: 0.88g (69%)
[0185] The product was purified according to Example 1 by its oxalate salt (81%).
[0186] Product purity: 99.4% (HPLC). The product was identical to the compound prepared in Example 1.
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com